Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Akebia: Is This A Potential Winner? [Seeking Alpha]

Akebia Therapeutics, Inc. (AKBA) 
Last akebia therapeutics, inc. earnings: 3/10 07:49 am Check Earnings Report
US:NASDAQ Investor Relations: ir.akebia.com/investor-relations
Company Research Source: Seeking Alpha
Akebia: Is This A Potential Winner? Summary The current bear market offers many high-quality companies that are on sales at a deep bargain. As we continue our bargain-hunting quest, we stumbled upon Akebia Therapeutics. The company recently completed its merger with Keryx Pharmaceuticals. Keryx’s approved medicine, Auryxia, provides increasing cash flow to help Akebia fund further pipeline innovation. We’ll assess whether Akebia will post positive clinical data its lead drug Vadadustat and whether it has good market potential. With every new wave of optimism or pessimism, we are ready to abandon history and time-tested principles, but we cling tenaciously and unquestioningly to our prejudices. - Benjamin Graham Back on Dec. 13, 2018, Keryx Pharmaceuticals and Akebia Therapeutics (NASDAQ: AKBA announced initially approved additional approval Figure 1: Akebia chart. (Source: StockCharts Fundamental Headquartered in Cambridge, Massachusetts, the newly-merged company (Akebia) is powering Show less Read more
Impact Snapshot
Event Time:
AKBA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for AKBA alerts
Opt-in for
AKBA alerts

from News Quantified
Opt-in for
AKBA alerts

from News Quantified